1. Celebrating Survivorship: Caitlin McClellan

    My name is Caitlin McClellan and I was diagnosed with Non-Hodgkin lymphoma in June 2015. I went through six months of chemotherapy and two years of maintenance with Rituxan. I am loving life! I got married in 2017 and went on a wonderful honeymoon to Nashville, Tennessee. While there, we decided to do a Light the Night walk and met Charles Esten! We have done many Light the Night walks. My team name even won some prizes! It is ode to the nodes!

    Read More
  2. The Leukemia & Lymphoma Society National Blood Cancer Conference

    Don't Miss The LLS Inaugural National Blood Cancer Conference-A Free VIRTUAL Educational Conference for Patients, Survivors, Caregivers and Healthcare Professionals. The conference will be held on Saturday, September 12, 2020 beginning at 11:30 am EST (ends 2:45 pm EST) and will feature expert speakers from around the country. This virtual Blood Cancer Conference (BCC) is one of many programs developed by The Leukemia & Lymphoma Society (LLS) to meet the needs of patients, surviv...

    Read More
  3. When the Insurance Says No to a Clinical Trial

    As an LLS Clinical Trial Nurse Navigator, Ashley Giacobbi works tirelessly to connect the right patient with the right clinical trial – work that has become increasingly complicated in the COVID-19 era. But recently, she went the extra mile to ensure a patient – a young healthcare worker whose AML had relapsed several times – could access a trial that offered a promising treatment option. The patient had reached out to LLS seeking a trial back in May. Giacobbi identified about 15 ...

    Read More
  4. August 2020-Patient and Caregiver Education Programs

    Please join your local chapter in the following education programs for patients and caregivers. Understanding Immunotherapy for Blood Cancers A Virtual Education Program August 24, 2020 (TXG) 6:00pm - 7:30pm (CT) https://na.eventscloud.com/ehome/558025 Managing Stress and Coping with Cancer A Virtual / Online Education Program August 25, 2020 (WI) 5:30PM – 7:00PM (CT) https://na.eventscloud.com/ehome/552293 Lymphoma: Emerging Therapies & Survivorship A Virtual Edu...

    Read More
  5. A New CAR-T Approval Brings Hope for Mantle Cell Lymphoma Patients

    The U.S. Food and Drug Administration (FDA) today announced its approval for a breakthrough treatment that will bring the promise of immunotherapy and new hope to thousands of patients diagnosed with mantle cell lymphoma (MCL) whose previous treatments fail to bring them lasting remissions. There are more than 70 subtypes of lymphoma, and MCL is a particularly aggressive form of this blood cancer with a short remission from standard therapies. The median overall survival rate is betwe...

    Read More
  6. Destroying Mutant Proteins as an Emerging Cancer Treatment: A Q&A with a New LLS TAP Partner

    Kymera Therapeutics is a biotech company pioneering an emerging approach to cancer therapy called “targeted protein degradation.” Whereas most targeted therapies inhibit or inactivate the proteins or genes that drive the cancer, targeted protein degradation harnesses the body’s natural system of ridding itself of unwanted, ‘old’ or ‘broken’ components of cells. In March 2020, LLS made a strategic investment in Kymera’s work to treat blood-based cancers through our Therapy Acce...

    Read More
  7. Collaborating for Cures: Spotlight on Blood Cancer Research

    Labs are eerily quiet. Clinical trials have been paused. Cancer researchers – particularly those who are early in their careers – are facing unprecedented uncertainty. The global COVID-19 pandemic has not only upended every aspect of cancer care for patients and their families, but also halted critical research around the world. In addition to lab closures, many institutions and organizations have been forced to scale back their investments in research, creating unexpected funding shortag...

    Read More
  8. Celebrating Survivorship: Katherine Albert

    Hello! My name is Katherine and I was diagnosed in January 2020 with Stage IV classical Hodgkin's Lymphoma. My diagnosis came after months of fatigue and diffuse body pain. Initially I was evaluated for lupus or RA, but those diagnoses didn't quite fit. After discussing with my PCP again and noting a persistent cough, a CT and PET-CT showed diffuse lymphadenopathy and lesions on my liver and spleen. Shortly after diagnosis I started treatment in a clinical trial with AVD+Opdivo. The r...

    Read More
  9. July 2020-Patient Education Programs

    Cancer Survivorship: Living Through & Beyond Blood Cancer A Virtual / Online Education Program July 15, 2020 (CTX) 6:00PM – 8:00PM (CT) https://bit.ly/2ZnBNdc Symptoms, Treatment, and the Role of Clinical Trials A Virtual / Online Education Program July 15, 2020 (Gateway) 11:00AM – 12:00PM (CT) https://na.eventscloud.com/556482 Clinical Updates for Blood Cancers A Virtual / Online Education Program July 25, 2020 (New England) 10:00AM – 12:00PM (ET) https://n...

    Read More